2021
DOI: 10.1016/j.endmts.2021.100085
|View full text |Cite
|
Sign up to set email alerts
|

A review: Brief insight into Polycystic Ovarian syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
47
0
10

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 89 publications
(57 citation statements)
references
References 82 publications
0
47
0
10
Order By: Relevance
“…Polycystic ovary syndrome (PCOS) is a common endocrine disease (with variable prevalence worldwide, ranging from 6% to 26%) [ 14 ], which is characterized by anovulation, clinical or biochemical hyperandrogenemia and polycystic ovary morphology [ 15 ]. Hyperinsulinemia as a result of tissue insulin resistance, is central to PCOS [ 16 ].…”
Section: Gender-specific Use Of Mtfmentioning
confidence: 99%
“…Polycystic ovary syndrome (PCOS) is a common endocrine disease (with variable prevalence worldwide, ranging from 6% to 26%) [ 14 ], which is characterized by anovulation, clinical or biochemical hyperandrogenemia and polycystic ovary morphology [ 15 ]. Hyperinsulinemia as a result of tissue insulin resistance, is central to PCOS [ 16 ].…”
Section: Gender-specific Use Of Mtfmentioning
confidence: 99%
“…According to the World Health Organization (WHO) estimation revealed over 116 million women (3.4%) are affected by (PCOS) worldwide [1]. Owing to the intricacy of this condition, various sets of diagnostic criteria have been initiated for the confirmation of (PCOS) which are: National [2]. The prevalence of (PCOS) is estimated at about 4 to 21 % when it is diagnosed according to the Rotterdam criteria.…”
Section: Introductionmentioning
confidence: 99%
“…Sendo assim, foram realizados vários consensos para estabelecer critérios para o diagnóstico da SOP, como o do National Institutes of Health (NIH), o de Rotterdam e o da Sociedade de hiperandrogênio e Síndrome dos Ovários Policísticos (AES-PCOS) (Azziz el al., 2006), contudo o mais utilizado é o Consenso de Rotterdam (2004), que estabelece a presença de dois dos três critérios: ovários policísticos ao ultrassom pélvico/transvaginal de 12 ou mais folículos periféricos e/ou volume ovariano superior a 10cm 3 , oligo/anovulação (distúrbios menstruais) e por sinais clínicos e/ou laboratoriais de hiperandrogenismo. O diagnóstico de SOP só pode ser firmado após a exclusão de outras causas de hiperandrogenismo, como disfunções tireoidianas, hiperprolactinemias, hiperplasia adrenal congênita de manifestação tardia e tumores secretores de androgênios (Bulsara et al, 2021).…”
Section: Introductionunclassified
“…Sendo assim, dentre as opções de tratamentos, tem-se o medicamentoso, incluindo hormônios, drogas antidiabéticas, diuréticos e o tratamento não-medicamentoso, que relaciona as terapias alternativas, como a yoga, até práticas de exercícios físicos (Bulsara et al, 2021).…”
Section: Introductionunclassified